HiPPIP
Home
About
SZ Genes
People
Help
Advanced Search
FGFR3 and FGF4
Number of citations of the paper that reports this interaction (PubMedID
8663044
)
422
Data Source:
HPRD
(in vitro)
FGFR3
FGF4
Description
fibroblast growth factor receptor 3
fibroblast growth factor 4
Image
GO Annotations
Cellular Component
Extracellular Region
Nucleus
Endoplasmic Reticulum
Golgi Apparatus
Plasma Membrane
Integral Component Of Plasma Membrane
Focal Adhesion
Cell Surface
Transport Vesicle
Receptor Complex
Extracellular Region
Extracellular Space
Cytoplasm
Molecular Function
Protein Tyrosine Kinase Activity
Transmembrane Receptor Protein Tyrosine Kinase Activity
Fibroblast Growth Factor-activated Receptor Activity
Protein Binding
ATP Binding
Fibroblast Growth Factor Binding
Identical Protein Binding
Fibroblast Growth Factor Receptor Binding
Growth Factor Activity
Heparin Binding
Biological Process
MAPK Cascade
Skeletal System Development
Endochondral Ossification
Chondrocyte Differentiation
Endochondral Bone Growth
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway
Cell-cell Signaling
Multicellular Organism Development
Positive Regulation Of Cell Population Proliferation
Fibroblast Growth Factor Receptor Signaling Pathway
Positive Regulation Of Phospholipase Activity
Peptidyl-tyrosine Phosphorylation
Bone Mineralization
Positive Regulation Of Kinase Activity
Chondrocyte Proliferation
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein
Positive Regulation Of MAPK Cascade
Positive Regulation Of Phosphatidylinositol 3-kinase Activity
Protein Autophosphorylation
Negative Regulation Of Developmental Growth
Bone Morphogenesis
Positive Regulation Of ERK1 And ERK2 Cascade
Bone Maturation
Fibroblast Growth Factor Receptor Apoptotic Signaling Pathway
Cartilage Condensation
Positive Regulation Of Protein Phosphorylation
Signal Transduction
Cell-cell Signaling
Positive Regulation Of Cell Population Proliferation
Fibroblast Growth Factor Receptor Signaling Pathway
Animal Organ Morphogenesis
Mesenchymal Cell Proliferation
Positive Regulation Of Gene Expression
Stem Cell Population Maintenance
Cell Differentiation
Regulation Of Cell Migration
Embryonic Hindlimb Morphogenesis
Odontogenesis Of Dentin-containing Tooth
Negative Regulation Of Apoptotic Process
Positive Regulation Of Transcription By RNA Polymerase II
Positive Regulation Of Cell Division
Cranial Suture Morphogenesis
Apoptotic Process Involved In Morphogenesis
Chondroblast Differentiation
Positive Regulation Of ERK1 And ERK2 Cascade
Cellular Response To Leukemia Inhibitory Factor
Regulation Of Endothelial Cell Chemotaxis To Fibroblast Growth Factor
Pathways
Signaling by activated point mutants of FGFR3
FGFR3 mutant receptor activation
t(4;14) translocations of FGFR3
Signaling by FGFR3 fusions in cancer
Signaling by FGFR3 point mutants in cancer
PI3K Cascade
PIP3 activates AKT signaling
Signaling by activated point mutants of FGFR1
Signaling by activated point mutants of FGFR3
FGFR4 ligand binding and activation
FGFR3c ligand binding and activation
FGFR1c ligand binding and activation
FGFR2c ligand binding and activation
FGFR3 mutant receptor activation
Activated point mutants of FGFR2
Constitutive Signaling by Aberrant PI3K in Cancer
Phospholipase C-mediated cascade: FGFR1
Phospholipase C-mediated cascade; FGFR2
Phospholipase C-mediated cascade; FGFR3
Phospholipase C-mediated cascade; FGFR4
Downstream signaling of activated FGFR1
SHC-mediated cascade:FGFR1
PI-3K cascade:FGFR1
FRS-mediated FGFR1 signaling
PI-3K cascade:FGFR2
SHC-mediated cascade:FGFR2
FRS-mediated FGFR2 signaling
SHC-mediated cascade:FGFR3
FRS-mediated FGFR3 signaling
PI-3K cascade:FGFR3
FRS-mediated FGFR4 signaling
SHC-mediated cascade:FGFR4
PI-3K cascade:FGFR4
Negative regulation of FGFR1 signaling
Negative regulation of FGFR2 signaling
Negative regulation of FGFR3 signaling
Negative regulation of FGFR4 signaling
Signaling by FGFR2 in disease
Signaling by FGFR1 in disease
FGFRL1 modulation of FGFR1 signaling
RAF/MAP kinase cascade
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
Signaling by FGFR3 point mutants in cancer
Drugs
XL999
Pazopanib
Ponatinib
Lenvatinib
Nintedanib
Fostamatinib
Erdafitinib
Pemigatinib
Selpercatinib
Pentosan polysulfate
Heparin
TP-508
Diseases
GWAS
Bladder cancer (
24163127
20972438
)
Blood protein levels (
30072576
)
Hip circumference adjusted for BMI (
34021172
)
Metabolite levels (
23823483
)
Urinary bladder cancer (
20348956
)
Birth weight (
31043758
)
Breast cancer (
20453838
)
Craniofacial microsomia (
26853712
)
Gut microbiota (bacterial taxa, hurdle binary method) (
32572223
)
Urate levels in overweight individuals (
25811787
)
Interacting Genes
49 interacting genes:
ADD1
ANOS1
ARAP1
ATF3
BORA
C6orf47
CCDC17
CEP126
CHGB
CTSK
EPHA4
ERBB2
FGF1
FGF17
FGF18
FGF2
FGF23
FGF3
FGF4
FGF5
FGF6
FGF7
FGF8
FGF9
GMPS
GPSM3
GRB2
GRK4
GTF3C1
HBZ
HNRNPL
IDUA
IRF2BPL
KRT8
NDUFS6
NECTIN1
POLA2
PTK2B
RADIL
RNF130
RPL8
RPS6KA3
SH2B1
SLC25A6
SMG7
SRPK2
STAT1
STAT3
STK32B
5 interacting genes:
FGFR1
FGFR2
FGFR3
FGFR4
NRP1
Entrez ID
2261
2249
HPRD ID
00624
01294
Ensembl ID
ENSG00000068078
ENSG00000075388
Uniprot IDs
P22607
Q0IJ44
P08620
PDB IDs
1RY7
2LZL
4K33
6LVM
6PNX
7DHL
1IJT
Enriched GO Terms of Interacting Partners
?
Tagcloud
?
Tagcloud (Difference)
?
Tagcloud (Intersection)
?